Quality of life in adults with dysferlinopathy: international clinical outcome study of dysferlinopathy

被引：0

作者：

Hilsden, H. ^{[1
,2
]}

James, M. ^{[1
,2
]}

Dressman, H. Gordish ^{[3
,4
]}

Day, J. ^{[5
]}

Mendell, J. ^{[6
]}

Torron, R. Fernandez ^{[7
]}

Harms, M. ^{[8
]}

Pestronk, A. ^{[9
]}

Vissing, J. ^{[10
]}

Desai, U. ^{[11
]}

Yoshimura, M. ^{[12
]}

Shin, J. ^{[13
]}

Mozaffar, T. ^{[14
]}

Stojkovic, T. ^{[15
]}

Pegoraro, E. ^{[16
]}

Raivas, J. Bevilacqu ^{[17
]}

Olive, M. ^{[18
]}

Paradas, C. ^{[19
]}

Straub, V. ^{[1
,2
]}

Mayhew, A. ^{[1
,2
]}

机构：

[1] Newcastle Univ, Translat & Clin Res Inst, John Walton Muscular Dystrophy Res Ctr, Newcastle Upon Tyne, Tyne & Wear, England

[2] Newcastle Hosp NHS Fdn Trust, Newcastle, NSW, Australia

[3] Childrens Nat Hlth Syst, Div Biostats Study Methodol, Ctr Translat Sci, Washington, DC USA

[4] George Washington Univ, Paediat Epidemiol & Biostat, Washington, DC USA

[5] Stanford Univ, Dept Neurol & Neurol Sci, Sch Med, Stanford, CA USA

[6] Nationwide Ch Hosp, Columbus, OH USA

[7] Donostia Univ Hosp, Biodonostia Hlth Res Inst, Neurol Serv, Neuromuscular Area, Donostia San Sebastian, Spain

[8] Columbia Univ, Dept Neurol, Irving Med Ctr, New York, NY USA

[9] Washington Univ, Dept Neurol, Sch Med, St Louis, MO USA

[10] Univ Copenhagen, Dept Neurol, Rigshosp, Copenhagen Neuromusc Ctr, Copenhagen, Denmark

[11] Atrium Hlth, Carolinas MDA Care Ctr, Charlotte, NC USA

[12] NCNP, Dept Neurol, Nat Ctr Hosp, Tokyo, Japan

[13] Pusan Natl Univ, Lab Mol Neurol, Yangsan Hosp, Yangsan, South Korea

[14] Univ Calif Irvine, Dept Neurol, MDA ALS & Neuromusc Ctr, Orange, CA USA

[15] Grp Hosp Pitie Salpetriere, Inst Myol, Paris, France

[16] Univ Padua, Dept Neurosci, Padua, Italy

[17] Clin Davila, Dept Neurol & Neurocirugia Clin, Santiago, Chile

[18] Hosp Santa Creu & Sant Pau, Dept Neurol, Neuromusc Disord Unit, Barcelona, Spain

[19] Hosp Univ Virgen del Rocio, Dept Neurol, Neuromuscular Unit, Inst Biomed Sevilla, Seville, Spain

来源：

NEUROMUSCULAR DISORDERS | 2023年 / 33卷

关键词：

D O I：

10.1016/j.nmd.2023.07.191

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

P281

引用

页码：S113 / S113

页数：1

共 50 条

[31] RASCH ANALYSIS OF THE INDIVIDUALIZED NEUROMUSCULAR QUALITY OF LIFE QUESTIONNAIRE ADMINISTERED TO PATIENTS WITH DYSFERLINOPATHY
Mayhew, A. G.
James, M. K.
Jacobs, M.
Feng, Jia
Spuler, S.
Day, J. W.
Jones, K. J.
Bharucha-Goebel, D. X.
Salort-Campana, E.
Pestronk, A.
Walter, M. C.
Paradas, C.
Stojkovic, T.
Mori-Yoshimura, M.
Bravver, E.
Manera, J. Diaz
Pegoraro, E.
Mendell, J. R.
Bushby, K.
Straub, V.
MUSCLE & NERVE, 2018, 58 : S20 - S20
[32] Rasch analysis of the individualised neuromuscular Quality of Life Questionnaire administered to patients with dysferlinopathy
James, M.
Mayhew, A.
Jacobs, M.
Spuler, S.
Day, J.
Jones, K.
Bharucha-Goebel, D.
Salort-Campana, E.
Pestronk, A.
Walter, M.
Paradas, C.
Stojkovic, T.
Mori-Yoshimura, M.
Bravver, E.
Diaz Manera, J.
Pegoraro, E.
Mendell, J.
Bushby, K.
Straub, V.
NEUROMUSCULAR DISORDERS, 2018, 28 : S35 - S35
[33] Dysferlinopathy: A clinical and histopathological study of 28 patients from India
Nalini, A.
Gayathri, N.
NEUROLOGY INDIA, 2008, 56 (03) : 379 - 385
[34] Clinical outcome study of dysferlinopathy: The impact of lower limb orthoses on gait- a longitudinal single case study
James, M.
Alcock, L.
Wong, K.
Richardson, M.
Straub, V.
Mayhew, A.
NEUROMUSCULAR DISORDERS, 2022, 32 : S115 - S115
[35] The clinical outcome study of dysferlinopathy: Muscle MRI pattern at baseline and longitudinal changes over one year
Mori-Yoshimura, M.
Fernandez-Torron, R.
Meredith, J.
Jabobs, M.
Smith, F.
Azzabou, N.
Manera, J. D.
Spuler, S.
Day, J. W.
Jones, K. J.
Bharucha-Goebel, D. X.
Salort-Campanak, E.
Pestronk, A.
Walter, M. C.
Paradas, C.
Stojkovic, T.
Bravver, E.
Pegoraro, E.
Mendell, J. R.
Straub, V.
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 819 - 819
[36] Dysferlinopathy in Egypt: Clinical, Pathological and Genetic characteristics
Fahmy, N. A.
Abd Elhady, A.
Abd El-Naser, A.
Ashour, S.
Etribi, A.
Nonaka, I.
Minami, N.
Suzuki, N.
Takahashi, T.
Aoki, M.
NEUROMUSCULAR DISORDERS, 2014, 24 (9-10) : 903 - 904
[37] Clinical outcome study of dysferlinopathy 2: Characterising involvement of the intrinsic muscles of the hand in LGMDR2
James, M.
Mayhew, A.
Gordish-Dressman, H.
Rufibach, L.
Wong, K.
Roper, W.
Holsten, S.
Lowes, L.
Duong, T.
Yochai, C.
Zabala Pardo, A.
Ogasawara, Y.
Rudolph, K.
Alarcon, S.
Weber, J.
Montiel Morillo, E.
Pedrosa-Hernandez, I.
Birnbaum, S.
Rojas Rojas, J.
Day, J.
Straub, V.
NEUROMUSCULAR DISORDERS, 2022, 32 : S115 - S115
[38] Late onset in dysferlinopathy widens the clinical spectrum
Klinge, L.
Dean, A. F.
Kress, W.
Dixon, P.
Charlton, R.
Mueller, J. S.
Anderson, L. V.
Straub, V.
Barresi, R.
Lochmueller, H.
Bushby, K.
NEUROMUSCULAR DISORDERS, 2008, 18 (04) : 288 - 290
[39] Clinical outcome measures for dysferlinopathy: An exploration of reliability and suitability of novel functional rating scales
Eagle, M.
Mayhew, A. G.
Bettinson, K.
James, M. K.
Von Rekowski, B.
Bushby, K.
NEUROMUSCULAR DISORDERS, 2013, 23 (9-10) : 764 - 765
[40] Dysferlinopathy in Switzerland: clinical phenotypes and potential founder effects
Petersen, Jens A.
Kuntzer, Thierry
Fischer, Dirk
von der Hagen, Maja
Huebner, Angela
Kana, Veronika
Lobrinus, Johannes A.
Kress, Wolfram
Rushing, Elisabeth J.
Sinnreich, Michael
Jung, Hans H.
BMC NEUROLOGY, 2015, 15

← 1 2 3 4 5 →